Literature DB >> 10543750

Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.

C R DeLoney1, N L Schiller.   

Abstract

The penicillin-binding proteins (PBPs) of helical (log-phase) Helicobacter pylori ATCC 43579 were identified by using biotinylated ampicillin. The major PBPs had apparent molecular masses of 47, 60, 63, and 66 kDa; an additional minor PBP of 95 to 100 kDa was also detected. The relative affinities of various beta-lactams for these PBPs were tested by competitive-binding assays. Only PBP63 appeared to be significantly bound to each of the competing antibiotics, whereas PBP66 strongly bound mezlocillin, oxacillin, amoxicillin, and ceftriaxone. Whereas most of the beta-lactams significantly bound two or more PBPs, aztreonam specifically targeted PBP63. The influence of sub-MICs of these beta-lactams on the morphologies of log-phase H. pylori was observed at both the phase-contrast and transmission electron microscopy levels. Each of the eight beta-lactams examined induced blebbing and sphere formation, whereas aztreonam was the only antibiotic studied which induced pronounced filamentation in H. pylori. Finally, studies comparing the PBPs of helical (log-phase) cultures with those of coccoid (7-, 14-, and 21-day-old) cultures of H. pylori revealed that the major PBPs at 60 and 63 kDa seen in the helical form were almost undetectable in the coccoid forms, whereas PBP66 remained the major PBP in the coccoid forms, although somewhat reduced in level compared to the helical form. PBP47 was present in both forms at approximately equal concentrations. These studies thus identified the major PBPs in both helical and coccoid forms of H. pylori and compared the relative affinities of seven different beta-lactams for the PBPs in the helical forms and their effects on bacterial morphology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543750      PMCID: PMC89546     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form.

Authors:  M Benaissa; P Babin; N Quellard; L Pezennec; Y Cenatiempo; J L Fauchère
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Morphologic conversion of Helicobacter pylori from bacillary to coccoid form.

Authors:  M Sörberg; M Nilsson; H Hanberger; L E Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

3.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Growth and morphological transformations of Helicobacter pylori in broth media.

Authors:  A P Andersen; D A Elliott; M Lawson; P Barland; V B Hatcher; E G Puszkin
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.

Authors:  M P Dore; A Piana; M Carta; A Atzei; B M Are; I Mura; G Massarelli; A Maida; A R Sepulveda; D Y Graham; G Realdi
Journal:  Aliment Pharmacol Ther       Date:  1998-07       Impact factor: 8.171

6.  Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.

Authors:  M I Brenciaglia; A M Fornara; M M Scaltrito; P C Braga; F Dubini
Journal:  J Chemother       Date:  1996-02       Impact factor: 1.714

7.  Diversity in protein synthesis and viability of Helicobacter pylori coccoid forms in response to various stimuli.

Authors:  H Mizoguchi; T Fujioka; K Kishi; A Nishizono; R Kodama; M Nasu
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  The pathogenic role of the coccoid form of Helicobacter pylori.

Authors:  S Vijayakumari; M M Khin; B Jiang; B Ho
Journal:  Cytobios       Date:  1995

Review 9.  Helicobacter pylori and gastrointestinal disease.

Authors:  M Gibaldi
Journal:  J Clin Pharmacol       Date:  1995-07       Impact factor: 3.126

10.  Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.

Authors:  V Berry; K Jennings; G Woodnutt
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  20 in total

1.  Peptidoglycan crosslinking relaxation promotes Helicobacter pylori's helical shape and stomach colonization.

Authors:  Laura K Sycuro; Zachary Pincus; Kimberley D Gutierrez; Jacob Biboy; Chelsea A Stern; Waldemar Vollmer; Nina R Salama
Journal:  Cell       Date:  2010-05-28       Impact factor: 41.582

2.  Analysis of aztreonam-inducing proteome changes in nondividing filamentous Helicobacter pylori.

Authors:  Chunhong Shao; Yabin Zhou; Yundong Sun; Hongyan Wang; Wei Qu; Han Yu; Chunyan Chen; Jihui Jia
Journal:  Curr Microbiol       Date:  2012-04-27       Impact factor: 2.188

3.  Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy.

Authors:  Boudewijn L M de Jonge; Amy Kutschke; Joseph V Newman; Michael T Rooney; Wei Yang; Christer Cederberg
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  Mutations to essential orphan response regulator HP1043 of Helicobacter pylori result in growth-stage regulatory defects.

Authors:  Igor N Olekhnovich; Serhiy Vitko; Olga Chertihin; Raquel Hontecillas; Monica Viladomiu; Josep Bassaganya-Riera; Paul S Hoffman
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

5.  Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

6.  Urease activity and urea gene sequencing of coccoid forms of H. pylori induced by different factors.

Authors:  Fusun Can; Ceren Karahan; Istar Dolapci; Muge Demirbilek; Alper Tekeli; Hande Arslan
Journal:  Curr Microbiol       Date:  2008-01-01       Impact factor: 2.188

7.  Dynamic localization of MreB in Vibrio parahaemolyticus and in the ectopic host bacterium Escherichia coli.

Authors:  Shen-Wen Chiu; Shau-Yan Chen; Hin-chung Wong
Journal:  Appl Environ Microbiol       Date:  2008-09-12       Impact factor: 4.792

8.  A microtiter plate-based beta-lactam binding assay for inhibitors of high-molecular-mass penicillin-binding proteins.

Authors:  Miglena Stefanova; Sudheer Bobba; William G Gutheil
Journal:  Anal Biochem       Date:  2009-09-11       Impact factor: 3.365

9.  Development of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori.

Authors:  Ivo G Boneca; Chantal Ecobichon; Catherine Chaput; Aurélie Mathieu; Stéphanie Guadagnini; Marie-Christine Prévost; Frédéric Colland; Agnès Labigne; Hilde de Reuse
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792

Review 10.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.